• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ICUI

    ICU Medical Inc.

    Subscribe to $ICUI
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

    IPO Year: 1992

    Exchange: NASDAQ

    Website: icumed.com

    Peers

    $EW

    Recent Analyst Ratings for ICU Medical Inc.

    DatePrice TargetRatingAnalyst
    8/15/2025$145.00Overweight
    Piper Sandler
    3/12/2025$205.00 → $197.00Outperform → Strong Buy
    Raymond James
    12/11/2024$200.00Hold → Buy
    Jefferies
    10/14/2024$183.00Hold
    Jefferies
    6/21/2024Hold
    Needham
    6/17/2024$135.00Mkt Perform → Outperform
    Raymond James
    11/8/2022Outperform → Mkt Perform
    Raymond James
    2/28/2022$286.00 → $265.00Outperform
    Raymond James
    10/22/2021$302.00 → $280.00Overweight
    Keybanc
    9/9/2021$220.00 → $286.00Outperform
    Raymond James
    See more ratings

    ICU Medical Inc. FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER issued to ICU MEDICAL INC

    Submission status for ICU MEDICAL INC's drug POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (SUPPL-8) with active ingredient POTASSIUM CHLORIDE; SODIUM CHLORIDE has changed to 'Approval' on 05/15/2023. Application Category: ANDA, Application Number: 078446, Application Classification: Labeling

    5/17/23 4:40:03 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Jain Vivek bought $2,474,375 worth of shares (21,929 units at $112.84), increasing direct ownership by 20% to 130,149 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    8/14/25 7:07:45 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Jain Vivek bought $2,474,375 worth of shares (21,929 units at $112.84), increasing direct ownership by 20% to 130,149 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    8/14/25 7:07:45 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    VP, General Counsel Sanzone Virginia Ruth sold $93,537 worth of shares (700 units at $133.62), decreasing direct ownership by 10% to 6,386 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/30/25 2:34:28 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Chief Operating Officer Voigtlander Christian B. exercised 11,115 shares at a strike of $96.83 and sold $1,288,371 worth of shares (9,930 units at $129.75), increasing direct ownership by 24% to 6,088 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/28/25 12:00:55 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Chief Operating Officer Voigtlander Christian B. exercised 11,110 shares at a strike of $96.83 and sold $1,289,502 worth of shares (9,918 units at $130.02), increasing direct ownership by 32% to 4,903 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/23/25 5:01:34 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Chief Operating Officer Voigtlander Christian B. sold $1,321,840 worth of shares (9,788 units at $135.05) and exercised 11,110 shares at a strike of $96.83, increasing direct ownership by 55% to 3,711 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/21/25 4:23:28 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Director Finney Elisha W sold $83,353 worth of shares (600 units at $138.92), decreasing direct ownership by 16% to 3,252 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/20/25 11:48:13 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Chief Operating Officer Voigtlander Christian B. exercised 11,110 shares at a strike of $96.83 and sold $1,544,314 worth of shares (11,110 units at $139.00) (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/19/25 5:28:53 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Chief Operating Officer Voigtlander Christian B. sold $1,523,301 worth of shares (11,111 units at $137.10) and exercised 11,111 shares at a strike of $96.83 (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/15/25 4:57:09 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Chief Information Officer Sousa Ben sold $274,714 worth of shares (2,000 units at $137.36), decreasing direct ownership by 81% to 479 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/15/25 4:55:39 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Director Finney Elisha W converted options into 1,723 shares, increasing direct ownership by 81% to 3,852 units (SEC Form 4)

    4 - ICU MEDICAL INC/DE (0000883984) (Issuer)

    5/14/25 11:02:16 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. SEC Filings

    View All

    SEC Form S-8 filed by ICU Medical Inc.

    S-8 - ICU MEDICAL INC/DE (0000883984) (Filer)

    8/8/25 4:05:53 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by ICU Medical Inc.

    10-Q - ICU MEDICAL INC/DE (0000883984) (Filer)

    8/7/25 4:17:58 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ICU MEDICAL INC/DE (0000883984) (Filer)

    8/7/25 4:11:06 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SD filed by ICU Medical Inc.

    SD - ICU MEDICAL INC/DE (0000883984) (Filer)

    5/30/25 5:19:26 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - ICU MEDICAL INC/DE (0000883984) (Filer)

    5/14/25 2:49:34 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by ICU Medical Inc.

    10-Q - ICU MEDICAL INC/DE (0000883984) (Filer)

    5/8/25 5:06:47 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ICU MEDICAL INC/DE (0000883984) (Filer)

    5/8/25 4:08:03 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by ICU Medical Inc.

    DEFA14A - ICU MEDICAL INC/DE (0000883984) (Filer)

    4/3/25 1:20:23 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by ICU Medical Inc.

    DEF 14A - ICU MEDICAL INC/DE (0000883984) (Filer)

    4/3/25 1:19:38 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by ICU Medical Inc.

    10-K - ICU MEDICAL INC/DE (0000883984) (Filer)

    2/27/25 5:24:45 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on ICU Medical with a new price target

    Piper Sandler initiated coverage of ICU Medical with a rating of Overweight and set a new price target of $145.00

    8/15/25 8:19:19 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical upgraded by Raymond James with a new price target

    Raymond James upgraded ICU Medical from Outperform to Strong Buy and set a new price target of $197.00 from $205.00 previously

    3/12/25 7:28:15 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical upgraded by Jefferies with a new price target

    Jefferies upgraded ICU Medical from Hold to Buy and set a new price target of $200.00

    12/11/24 7:52:44 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Jefferies initiated coverage on ICU Medical with a new price target

    Jefferies initiated coverage of ICU Medical with a rating of Hold and set a new price target of $183.00

    10/14/24 7:34:44 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Needham initiated coverage on ICU Medical

    Needham initiated coverage of ICU Medical with a rating of Hold

    6/21/24 6:50:11 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical upgraded by Raymond James with a new price target

    Raymond James upgraded ICU Medical from Mkt Perform to Outperform and set a new price target of $135.00

    6/17/24 7:43:41 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical downgraded by Raymond James

    Raymond James downgraded ICU Medical from Outperform to Mkt Perform

    11/8/22 6:18:57 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Raymond James reiterated coverage on ICU Medical with a new price target

    Raymond James reiterated coverage of ICU Medical with a rating of Outperform and set a new price target of $265.00 from $286.00 previously

    2/28/22 5:11:33 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Keybanc reiterated coverage on ICU Medical with a new price target

    Keybanc reiterated coverage of ICU Medical with a rating of Overweight and set a new price target of $280.00 from $302.00 previously

    10/22/21 4:41:12 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Raymond James reiterated coverage on ICU Medical with a new price target

    Raymond James reiterated coverage of ICU Medical with a rating of Outperform and set a new price target of $286.00 from $220.00 previously

    9/9/21 7:51:02 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    ICU Medical to Participate in Upcoming Investor Conferences

    SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September: Wells Fargo 2025 Healthcare Conference on September 4, 2025 Company management will participate in a fireside chat at the Wells Fargo 2025 Healthcare Conference in Boston on Thursday, September 4, 2025. The discussion will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be webcast live on the Event Calendar section of the Company's Investor Relations website at https://ir.icumed.com. A replay of the webcast will be archived on the website for

    8/21/25 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

    SAN CLEMENTE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2025. Second Quarter 2025 Results Second quarter 2025 revenue was $548.9 million, as compared to $596.5 million in the same period in the prior year. GAAP gross profit for the second quarter of 2025 was $208.1 million, as compared to $207.4 million in the same period in the prior year. GAAP gross margin for the second quarter of 2025 was 38%, as compared to 35% in the same period in the prior year. GAAP net income for the second quarter of 202

    8/7/25 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call

    SAN CLEMENTE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2025 earnings release and conference call. The Company will release its second quarter 2025 results on Thursday, August 7, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, August 7, 2025. The call can be accessed at (800) 267-6316, conference ID "ICUMED". The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's

    7/24/25 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces First Quarter 2025 Results

    SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2025. First Quarter 2025 Results First quarter 2025 revenue was $604.7 million, as compared to $566.7 million in the same period in the prior year. GAAP gross profit for the first quarter of 2025 was $210.1 million, as compared to $185.2 million in the same period in the prior year. GAAP gross margin for the first quarter of 2025 was 35%, as compared to 33% in the same period in the prior year. GAAP net loss for the first quarter of 2025 was $(15.

    5/8/25 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America

    The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. SAN CLEMENTE, Calif. and TOKUSHIMA, Japan, May 1, 2025 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ:ICUI), a worldwide leader in the development, manufacture and sale of innovative medical devices, and Otsuka Pharmaceutical Factory, Inc. (OPF), a subsidiary of Otsuka Holdings Co., Ltd. engaged in the global manufacturing and sale of IV solutions, together announce the formation of Otsuka ICU Medical LLC—a new joint venture aimed at

    5/1/25 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call

    SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2025 earnings release and conference call. The Company will release its first quarter 2025 results on Thursday, May 8, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, May 8, 2025. The call can be accessed at (800) 225-9448, conference ID "ICUMED". The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's webs

    4/24/25 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps

    New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif., April 7, 2025 /PRNewswire/ -- ICU Medical Inc. (NASDAQ:ICUI), a worldwide leader in the development, manufacture and sale of innovative medical devices, has announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Solo™ precision IV pump, a single-channel complement to the dual-channel Plum Duo™. ICU Medical also received 510(k) clearance for updated versions of the Plum Duo precision IV pump and LifeShield™ infusion safety software, completing the initial launch of the ICU Medical IV Performance Platform. With these FDA clear

    4/7/25 8:00:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference

    SAN CLEMENTE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 24th Annual Needham Virtual Healthcare Conference being held April 7-10, 2025. ICU Medical's presentation will be on Monday, April 7, 2025 at 8:00 a.m. PT (11:00 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, April 7, 2025. The presentation will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will

    3/24/25 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical to Participate at the KeyBanc Healthcare Forum

    SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the KeyBanc Healthcare Forum being held virtually, March 18-19, 2025. ICU Medical's fireside chat will be on Wednesday, March 19, 2025 at 8:15 a.m. PT (11:15 a.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 19, 2025. The fireside chat will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar

    3/7/25 8:40:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance

    SAN CLEMENTE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2024. Fourth Quarter 2024 Results Fourth quarter 2024 revenue was $629.8 million, as compared to $587.9 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2024 was $227.3 million, as compared to $171.6 million in the same period in the prior year. GAAP gross margin for the fourth quarter of 2024 was 36.1%, as compared to 29.2% in the same period in the prior year. GAAP net loss for the fourth quarter of 2

    2/27/25 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. Leadership Updates

    Live Leadership Updates

    View All

    Carlyle Group and WP Carey Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Nov. 27, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, November 30: Carlyle Group Inc. (NASD: CG) will replace ICU Medical Inc. (NASD: ICUI) in the S&P MidCap 400. ICU Medical will replace PacWest Bancorp (NASD: PACW) in the S&P SmallCap 600. Banc of California Inc. (NYSE:BANC) is acquiring PacWest Bancorp in a deal expected to be completed soon, pending final closing conditions. Post-merger, Banc of California will remain in the S&P SmallCap 600. ICU Medical is more representative of the small-cap market space.WP Carey Inc. (NYSE: WPC) will replace Worthingt

    11/27/23 6:28:00 PM ET
    $AVTA
    $BANC
    $CG
    Finance: Consumer Services
    Finance
    Major Banks
    Investment Managers

    ICU Medical Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ICU Medical Inc.

    SC 13G/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    11/12/24 3:44:43 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by ICU Medical Inc.

    SC 13G/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    11/8/24 10:34:33 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by ICU Medical Inc.

    SC 13D/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    7/18/24 7:06:07 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by ICU Medical Inc.

    SC 13G - ICU MEDICAL INC/DE (0000883984) (Subject)

    2/13/24 3:14:39 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by ICU Medical Inc. (Amendment)

    SC 13G/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    2/8/24 10:14:32 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by ICU Medical Inc. (Amendment)

    SC 13G/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    1/10/24 10:16:57 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by ICU Medical Inc. (Amendment)

    SC 13G/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    12/11/23 11:38:45 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by ICU Medical Inc. (Amendment)

    SC 13G/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    2/14/23 12:40:51 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by ICU Medical Inc. (Amendment)

    SC 13G/A - ICU MEDICAL INC/DE (0000883984) (Subject)

    2/9/23 11:22:19 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by ICU Medical Inc.

    SC 13G - ICU MEDICAL INC/DE (0000883984) (Subject)

    2/6/23 2:53:12 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Inc. Financials

    Live finance-specific insights

    View All

    ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

    SAN CLEMENTE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2025. Second Quarter 2025 Results Second quarter 2025 revenue was $548.9 million, as compared to $596.5 million in the same period in the prior year. GAAP gross profit for the second quarter of 2025 was $208.1 million, as compared to $207.4 million in the same period in the prior year. GAAP gross margin for the second quarter of 2025 was 38%, as compared to 35% in the same period in the prior year. GAAP net income for the second quarter of 202

    8/7/25 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call

    SAN CLEMENTE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2025 earnings release and conference call. The Company will release its second quarter 2025 results on Thursday, August 7, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, August 7, 2025. The call can be accessed at (800) 267-6316, conference ID "ICUMED". The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's

    7/24/25 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces First Quarter 2025 Results

    SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2025. First Quarter 2025 Results First quarter 2025 revenue was $604.7 million, as compared to $566.7 million in the same period in the prior year. GAAP gross profit for the first quarter of 2025 was $210.1 million, as compared to $185.2 million in the same period in the prior year. GAAP gross margin for the first quarter of 2025 was 35%, as compared to 33% in the same period in the prior year. GAAP net loss for the first quarter of 2025 was $(15.

    5/8/25 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call

    SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2025 earnings release and conference call. The Company will release its first quarter 2025 results on Thursday, May 8, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, May 8, 2025. The call can be accessed at (800) 225-9448, conference ID "ICUMED". The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's webs

    4/24/25 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance

    SAN CLEMENTE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2024. Fourth Quarter 2024 Results Fourth quarter 2024 revenue was $629.8 million, as compared to $587.9 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2024 was $227.3 million, as compared to $171.6 million in the same period in the prior year. GAAP gross margin for the fourth quarter of 2024 was 36.1%, as compared to 29.2% in the same period in the prior year. GAAP net loss for the fourth quarter of 2

    2/27/25 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call

    SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2024 earnings release and conference call. The Company will release its fourth quarter 2024 results on Thursday, February 27, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, February 27, 2025. The call can be accessed at (800) 445-7795, conference ID "ICUMED". The conference call will be simultaneously available by webcast, which can be accessed by going to the Com

    2/13/25 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance

    SAN CLEMENTE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2024. Third Quarter 2024 Results Third quarter 2024 revenue was $589.1 million, as compared to $553.3 million in the same period in the prior year. GAAP gross profit for the third quarter of 2024 was $204.9 million, as compared to $183.9 million in the same period in the prior year. GAAP gross margin for the third quarter of 2024 was 34.8%, as compared to 33.2% in the same period in the prior year. GAAP net loss for the third quarter of 2024

    11/12/24 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call

    SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call. The Company will release its third quarter 2024 results on Tuesday, November 12th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, November 12th, 2024. The call can be accessed at (800) 343-5172, conference ID "ICUMED". The conference call will be simultaneously available by webcast, which can be accessed by going to the Com

    10/28/24 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Second Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance

    SAN CLEMENTE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2024. Second Quarter 2024 Results Second quarter 2024 revenue was $596.5 million, compared to $549.3 million in the same period in the prior year. GAAP gross profit for the second quarter of 2024 was $207.4 million, as compared to $192.3 million in the same period in the prior year. GAAP gross margin for the second quarter of 2024 and 2023 was 35%. GAAP net loss for the second quarter of 2024 was $(21.4) million, or $(0.88) per diluted share, as c

    8/7/24 4:05:00 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call

    SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its second quarter 2024 results on Wednesday, August 7th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Wednesday, August 7th, 2024. The call can be accessed at (800) 579-2543, conference ID "ICUMED". The conference call will be simultaneously available by webcast, which can be accessed by going to the C

    7/24/24 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care